iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Sandu Pharmaceuticals standalone net profit rises 55.17% in the December 2021 quarter

15 Feb 2022 , 08:50 AM

Net profit of Sandu Pharmaceuticals rose 55.17% to Rs 0.45 crore in the quarter ended December 2021 as against Rs 0.29 crore during the previous quarter ended December 2020. Sales rose 21.43% to Rs 19.15 crore in the quarter ended December 2021 as against Rs 15.77 crore during the previous quarter ended December 2020.

Particulars Quarter Ended
? Dec. 2021 Dec. 2020 % Var.
Sales 19.15 15.77 21
OPM % 4.02 3.11
PBDT 0.77 0.55 40
PBT 0.64 0.41 56
NP 0.45 0.29 55

Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.